Skip to main content
. 2012 Aug 20;14(5):732–737. doi: 10.1038/aja.2012.57

Figure 2.

Figure 2

The risk ratios of all variables for PFS in the patients with metastatic castration-resistant prostate cancer treated by ketoconazole therapy. The red point denotes the hazard rate, and the minor axis shows the hazard rate 95% confidence interval. AKP, alkaline phosphatase; PFS, progression-free survival; PSA, prostate-specific antigen; PSADT, PSA doubling time.